128 related articles for article (PubMed ID: 16574552)
1. Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.
Ceribelli A; Cecere FL; Milella M; Facciolo F; Gelibter A; Cognetti F
Lancet Oncol; 2006 Apr; 7(4):353. PubMed ID: 16574552
[No Abstract] [Full Text] [Related]
2. Pemetrexed and malignant pleural mesothelioma.
Marangolo M; Vertogen B
Ann Oncol; 2006 May; 17 Suppl 5():v103-5. PubMed ID: 16807435
[TBL] [Abstract][Full Text] [Related]
3. [Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].
Margery J
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S10-3. PubMed ID: 16273003
[No Abstract] [Full Text] [Related]
4. Pemetrexed (Alimta) for mesothelioma.
Med Lett Drugs Ther; 2004 Apr; 46(1180):31-2. PubMed ID: 15079145
[No Abstract] [Full Text] [Related]
5. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ
J Clin Oncol; 2003 Apr; 21(8):1556-61. PubMed ID: 12697881
[TBL] [Abstract][Full Text] [Related]
6. [Update of pemetrexed in thoracic oncology].
Brechot JM; Morère JF
Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed therapy for malignant pleural mesothelioma.
Puto K; Garey JS
Ann Pharmacother; 2005 Apr; 39(4):678-83. PubMed ID: 15755794
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.
Budde LS; Hanna NH
Expert Rev Anticancer Ther; 2004 Jun; 4(3):361-8. PubMed ID: 15161435
[TBL] [Abstract][Full Text] [Related]
9. Radiation recall dermatitis with pemetrexed.
Hureaux J; Le Guen Y; Tuchais C; Savary L; Urban T
Lung Cancer; 2005 Nov; 50(2):255-8. PubMed ID: 16111784
[TBL] [Abstract][Full Text] [Related]
10. TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.
Uramoto H; Onitsuka T; Shimokawa H; Hanagiri T
Anticancer Res; 2010 Oct; 30(10):4309-15. PubMed ID: 21036757
[TBL] [Abstract][Full Text] [Related]
11. Acute generalized exanthematous pustulosis-like drug eruption induced by pemetrexed.
Hattori T; Tamura A; Ishikawa O
Eur J Dermatol; 2011; 21(6):998-9. PubMed ID: 21896401
[No Abstract] [Full Text] [Related]
12. Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): a second line treatment option.
Razak AR; Chatten KJ; Hughes AN
Lung Cancer; 2008 May; 60(2):294-7. PubMed ID: 17919769
[TBL] [Abstract][Full Text] [Related]
13. Fatal pemetrexed-induced lung injury in patients with advanced mesothelioma: a report of two cases.
Nagata K; Kaji R; Tomii K
J Thorac Oncol; 2010 Oct; 5(10):1714-5. PubMed ID: 20871270
[No Abstract] [Full Text] [Related]
14. The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Mairinger F; Vollbrecht C; Mairinger T; Popper H
J Thorac Oncol; 2013 Aug; 8(8):e80-2. PubMed ID: 23857409
[No Abstract] [Full Text] [Related]
15. Pemetrexed and maintenance therapy for non-small cell lung cancer.
Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
[No Abstract] [Full Text] [Related]
16. The role of Alimta in the treatment of malignant pleural mesothelioma: an overview of preclinical and clinical trials.
Hanauske AR
Lung Cancer; 2004 Aug; 45 Suppl 1():S121-4. PubMed ID: 15261444
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of neoadjuvant chemotherapy with Pemetrexed (Alimta) in rectal cancer.
Derwinger K; Kodeda K; Swartling T; Kälebo P; Carlsson G; Gustavsson B
Eur J Surg Oncol; 2011 Jul; 37(7):583-8. PubMed ID: 21550200
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?
Zalcman G; Bergot E; Lechapt E
Lung Cancer; 2011 Apr; 72(1):1-2. PubMed ID: 21277041
[No Abstract] [Full Text] [Related]
19. Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?
Tamura K; Fujiwara Y
Asia Pac J Clin Oncol; 2010 Dec; 6(4):248-50. PubMed ID: 21114772
[No Abstract] [Full Text] [Related]
20. Pemetrexed-induced edema of the eyelid.
Kurata T; Tamura K; Okamoto I; Satoh T; Nakagawa K; Fukuoka M
Lung Cancer; 2006 Nov; 54(2):241-2. PubMed ID: 16996165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]